[Ip-health] Ex-FDA chief charged with lying about stock activities
Jeff Williams
jwkckid1@ix.netcom.com
Tue Oct 17 10:56:08 2006
All,
What does this say for the US FDA when in trade negotiations in
regards to drug issues?
See: http://www.govexec.com/story_page.cfm?articleid=35277&dcn=e_gvet
Former Food and Drug Administration Commissioner Lester Crawford
was charged Monday with lying about owning stock in companies that
were regulated by his agency.
The Justice Department accused him of falsely reporting he had sold
stock
in firms governed by FDA rules, the Associated Press reported. Justice
Department filings in U.S. District Court in Washington say Crawford
also
failed to report income from exercising stock options in Embrex, a
biotech
company regulated by the FDA.
Crawford resigned from the agency in September 2005, just two months
after Senate confirmation and a long stint as acting commissioner.
Regards,
--
Jeffrey A. Williams
Spokesman for INEGroup LLA. - (Over 134k members/stakeholders strong!)
"Obedience of the law is the greatest freedom" -
Abraham Lincoln
"Credit should go with the performance of duty and not with what is
very often the accident of glory" - Theodore Roosevelt
"If the probability be called P; the injury, L; and the burden, B;
liability depends upon whether B is less than L multiplied by
P: i.e., whether B is less than PL."
United States v. Carroll Towing (159 F.2d 169 [2d Cir. 1947]
===============================================================
Updated 1/26/04
CSO/DIR. Internet Network Eng. SR. Eng. Network data security
IDNS. div. of Information Network Eng. INEG. INC.
ABA member in good standing member ID 01257402
E-Mail jwkckid1@ix.netcom.com
Registered Email addr with the USPS
Contact Number: 214-244-4827